DOV

Rating neutralTentativeAI Memo

Dover

As of 2026-10-01/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-10-01 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Report quality notice

peer set is too generic or lacks enough direct operating comparators

Action

neutral

Confidence

medium

Horizon

—

Key catalyst

Third-quarter results on October 22 • 2026-10-22

Base target: $190 / p=50% prob

Biggest risk

Input-cost inflation could outpace pricing or productivity, and bookings may not convert into shipments at the expected pace. The raised outlook increases the consequence of a third-quarter shortfall. [#SEC-8K-2026-07-23]

Invalidation

Break below $155 or thesis failure.

What would change my mind?

Second-quarter revenue rose 7%, organic revenue rose 5%, and adjusted EPS rose 12%. Bookings exceeded shipments, all five segments posted positive organic growth, and Dover raised full-year adjusted EPS guidance to $10.55–$10.75. Sustained order conversion could support earnings upside. [#SEC-8K-2026-07-23]

Research note

Recommendation

neutral

Confidence

medium

As of

2026-10-01

Base target

$190

p=50%

Bull target

$215

p=25%

Bear target

$155

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Order momentum converts to second-half sales
Capacity and productivity investments
Second-quarter revenue rose 7%, organic revenue rose 5%, and adjusted EPS rose 12%.

BearKey bullets

Capacity and productivity projects have execution risk; the checked release does not establish a dated payoff.
[#SEC-8K-2026-07-23]
Input-cost inflation or weaker operating execution could pressure margins.

WatchKey bullets

Third-quarter results on October 22

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $190 (p=50%)

Target spread vs base: +13% / -18%

Scenario probabilities

Bull Target: $215 (p=25%)Base Target: $190 (p=50%)Bear Target: $155 (p=25%)

Commentary

The recent packet contains an earnings-date announcement but little independent post-guidance coverage. The supplied anchor predates the October 22 release; no post-release price reaction or verified analyst revisions exist yet. Zero-valued sentiment fields denote unavailable measurements, not neutral observed readings.

As of 2026-10-01 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Order momentum converts to second-half sales
Capacity and productivity investments

Scenarios

Bull Target (Scenario probability)

$215 / p=25% prob

Base Target (Scenario probability)

$190 / p=50% prob

Bear Target (Scenario probability)

$155 / p=25% prob

Analysis 2026-10-01 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.00

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-10-22
Third-quarter results on October 22
Dover scheduled its third-quarter earnings release for October 22. The decision point is whether results sustain the second quarter's 5% organic growth and support full-year adjusted EPS guidance of $10.55–$10.75. No third-quarter result is yet available. [#PR-EARNINGS-2026-09-16] [#SEC-8K-2026-07-23]
Prob 65.00% • Move 5.00% • Priced-in 50.00%

Short-term Catalysts

Next few weeks

Order momentum converts to second-half sales
2026-12-31
Second-quarter bookings grew double digits and exceeded shipments, according to Dover's earnings exhibit. Sustained conversion would support the raised outlook; weaker conversion would challenge it. The July 8-K identifies the attached earnings release. [#8-K-2026-07-23] [#SEC-8K-2026-07-23]
Prob 60% • Move 4% • Priced-in 55%

Long-term Catalysts

Months to a year

Capacity and productivity investments
2027-06-30
Management said it advanced capacity-expansion and productivity projects in the second quarter. Margin benefits are a potential longer-term outcome, not a disclosed dated milestone; mid-2027 is an assessment horizon. [#SEC-8K-2026-07-23]
Prob 55% • Move 5% • Priced-in 35%

Risks

Capacity and productivity projects have execution risk; the checked release does not establish a dated payoff. [#SEC-8K-2026-07-23]
Input-cost inflation or weaker operating execution could pressure margins. [#SEC-8K-2026-07-23]
Order strength may not translate into second-half revenue at the pace implied by management's outlook. [#SEC-8K-2026-07-23]
Third-quarter results could fail to support raised full-year adjusted EPS guidance. [#SEC-8K-2026-07-23] [#PR-EARNINGS-2026-09-16]

Peers

Symbol	Summary
EMR	Emerson's Final Control business supplies valves, actuators and regulators, making it an operating comparison for process-equipment demand, not for all five Dover segments. Its broader automation and software mix limits whole-company valuation comparability. Emerson 2026 Form 10-Q
IR	Ingersoll Rand's Precision and Science Technologies business handles industrial liquids and gases, providing a closer segment-level comparison for Dover's Pumps & Process Solutions. Its second-quarter organic orders rose 7%, versus Dover's double-digit company-wide bookings growth; these differently scoped measures are not directly comparable. Ingersoll Rand Q2 release [#SEC-8K-2026-07-23]

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-10-01

Loading AI feed…

Symbol

Summary

EMR

Emerson's Final Control business supplies valves, actuators and regulators, making it an operating comparison for process-equipment demand, not for all five Dover segments. Its broader automation and software mix limits whole-company valuation comparability. Emerson 2026 Form 10-Q

Ingersoll Rand's Precision and Science Technologies business handles industrial liquids and gases, providing a closer segment-level comparison for Dover's Pumps & Process Solutions. Its second-quarter organic orders rose 7%, versus Dover's double-digit company-wide bookings growth; these differently scoped measures are not directly comparable. Ingersoll Rand Q2 release [#SEC-8K-2026-07-23]